Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples
Authors:
Open Access
- 3 November 2008
- journal article
- clinical trial
- Published by Wiley in Cancer Science
- Vol. 99 (11) , 2193-2199
Abstract
Endoscopic biopsy prior to chemotherapy provides an opportunity for studying biomarkers to predict the overall survival in gastric cancer patients. This prospective study was performed to identify prognostic biomarkers in patients with unresected gastric cancer. Fifty‐nine cases of chemotherapy‐naive metastatic gastric cancer were enrolled in this study. A microarray analysis was performed using 40 biopsy samples to identify candidate genes whose expressions might be correlated with the overall survival. After adjusting for clinical covariates based on a multivariate analysis, the identified genes were validated using real‐time reverse transcription polymerase chain reaction (RT‐PCR) analysis in 19 independent validation samples. Ninety‐eight candidate genes whose expression levels were significantly correlated with the overall survival were identified using a microarray analysis based on a proportional hazards model (P < 0.005). Multivariate analysis was performed to assess 10 of these genes, and the results yielded a statistical significance level for DACH1 and PDCD6. We further evaluated these two genes in independent samples using real‐time RT‐PCR and found that lower mRNA expression levels of PDCD6 were correlated significantly with a poor overall survival. We identified PDCD6 as a prognostic biomarker in patients with unresected gastric cancer using endoscopic biopsy samples. Our PCR‐based single gene prediction strategy successfully predicted the overall survival and may lead to a better understanding of this disease subgroup. (Cancer Sci 2008; 99: 2193–2199)Keywords
This publication has 24 references indexed in Scilit:
- Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancerJournal of Clinical Pathology, 2006
- Identification of expressed genes characterizing long-term survival in malignant glioma patientsOncogene, 2006
- Gene Expression Profile Predicts Patient Survival of Gastric Cancer After Surgical ResectionJournal of Clinical Oncology, 2005
- Multivariate Prognostic Factor Analysis in Locally Advanced and Metastatic Esophago-Gastric Cancer—Pooled Analysis From Three Multicenter, Randomized, Controlled Trials Using Individual Patient DataJournal of Clinical Oncology, 2004
- Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasisProceedings of the National Academy of Sciences of the United States of America, 2002
- Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR‐beta in intestinal, diffuse–adherent, and diffuse–scattered type gastric carcinomasThe Journal of Pathology, 2002
- CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinomaCarcinogenesis, 2002
- Phase II Study of S-1, a Novel Oral Derivative of 5-Fluorouracil, in Advanced Gastric CancerOncology, 2000
- Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur–0.4M gimestat–1M otastat potassium) in advanced gastric cancer patientsEuropean Journal of Cancer, 1998
- Interfering with Apoptosis: Ca 2+ -Binding Protein ALG-2 and Alzheimer's Disease Gene ALG-3Science, 1996